Table 2.

Liver function, renal function, blood glucose, and blood lipids in each group at the end point

Parameter	Control	DEHP	DEHP + LbGp	Flutamide
ALT (U/L)	53.38 ± 12.44	64.18 ± 9.46	79.43 ± 19.75#	42.79 ± 9.14*
AST (U/L)	210.09 ± 49.48	224.06 ± 57.16	235.79 ± 70.76	205.73 ± 43.47
ALB (g/L)	48.46 ± 5.66	48.29 ± 4.64	47.80 ± 5.68	49.61 ± 3.88
GLU (mmol/L)	6.78 ± 1.28	5.28 ± 0.78#	6.90 ± 1.01*	6.02 ± 0.79
Urea (mg/dL)	25.21 ± 4.66	21.54 ± 5.04	24.61 ± 5.73	24.17 ± 6.51
CREA (μmol/L)	25.51 ± 11.65	28.93 ± 13.13	31.91 ± 12.32	26.43 ± 11.28
UA (μmol/L)	142.45 ± 26.37	176.02 ± 74.22	167.67 ± 33.62	205.95 ± 60.86
TG (mmol/L)	1.45 ± 0.41	1.05 ± 0.14#	0.92 ± 0.13##	1.33 ± 0.22
HDL (mmol/L)	1.94 ± 0.12	1.82 ± 0.14	2.02 ± 0.19	2.08 ± 0.18*
LDL (mmol/L)	0.26 ± 0.05	0.40 ± 0.11#	0.38 ± 0.08#	0.36 ± 0.04

Data are expressed as the mean ± standard deviation

DEHP, di(2-ethylhexyl) phthalate; LbGp, Lycium barbarum glycopeptide; ALT, alanine aminotransferase; AST, aspartate aminotransferase; ALB, albumin; GLU, glucose; CREA, creatinine; UA, uric acid; TG, triglyceride; HDL, high-density lipoprotein; LDL, low-density lipoprotein

^#P < 0.05 and ^##P < 0.01 compared with the control group. ^*P < 0.05 compared with the DEHP group